[ XXXX , @entity115 and @entity4581 in the treatment of helicobacterpylori, in 7 and 10-day regimens].

@entity1 @entity115 @entity575 @entity4581 @entity281 @entity1534 @entity4546
AIM: The most accepted treatment for @entity281 by @entity1534 is the proton pump inhibitor based therapy with two antibiotics. However, there is no consensus regarding the duration. The purpose here was to compare eradication percentages in the @entity4546 + @entity115 + @entity4581 regimen administered during 7 days versus 10 days and confront the results with a previous 14-day* experience in Peru. METHOD: @entity1 from the Central Military Hospital and Peruvian-Japanese Hospital evidencing chronic upper gastrointestinal tract symptoms were recruited. We excluded @entity1 with peptic ulcer. Biopsies were taken for diagnosis, for urease and PCR tests, culture and coloring with @entity575 . @entity4546 + @entity4581 + @entity115 was used during 7 days versus 10 days. Control endoscopy was performed one month after treatment had been completed and molecular biology techniques were used to differentiate recurrences from new infections. Susceptibility to @entity4581 was assessed. RESULTS: 36 @entity1 were included in each group. Eradication was the same in both groups: 86.1% (31/36). In several @entity1 in whom the bacteria persisted, the same initial nucleus was found. In a previous study* using this same regimen during 14 days, a 93% eradication was obtained. 91.18% of our samples were susceptible to @entity4581 . CONCLUSIONS: In Peru, the @entity4546 + @entity4581 + @entity115 combination gives results higher than 80% in the eradication of @entity281 by @entity1534 . The 7 and 10 days regimens eradicated the bacteria in 86% of our @entity1 .
